Related Experiment Video
Updated: Jun 16, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Reprint of: Pharmacist-led hypertension management in a minority patient population
Insights
Pharmacist-led interventions significantly improved blood pressure control in minority adults with hypertension. This approach, utilizing electronic health records, demonstrated a 70.9% success rate in achieving target blood pressure goals.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Hypertension affects nearly half of American adults, with lower control rates among minority populations.
- Pharmacist-led interventions show promise in improving blood pressure management and reducing cardiovascular risk.
Purpose of the Study:
- To assess the effectiveness of pharmacist-led interventions in improving blood pressure control among minority patients with uncontrolled hypertension, using electronic health record data.
Main Methods:
- A prospective cohort study involving 110 patients with uncontrolled hypertension from a suburban internal medicine practice.
- Patients were categorized into an intervention group and a control group, with the primary outcome being the proportion achieving blood pressure < 140/90 mm Hg.
Main Results:
- The intervention group achieved a blood pressure of < 140/90 mm Hg in 70.9% of patients, compared to 32.7% in the control group (P < 0.001).
- Common interventions included lifestyle modifications, blood pressure monitoring education, and medication adherence support.
Conclusions:
- Pharmacist-led interventions are effective in achieving clinically and statistically significant improvements in blood pressure control for minority populations with hypertension.
Background:
Nearly half of adults in America have hypertension (HTN), and only approximately 1 in 4 adults has their blood pressure (BP) under control. High BP is more common in African Americans adults, and BP control is lower among minority adults. Pharmacist-led interventions for HTN have been shown to be effective in improving BP control and reducing the risk of cardiovascular events.
Objective:
This study aimed to leverage electronic health record (EHR) data to improve BP control through pharmacist-led interventions.
Methods:
This was a prospective, cohort study conducted at Atrium Health Concord Internal Medicine, a large suburban practice in Concord, North Carolina. Patients with uncontrolled HTN were identified using an EHR data tool. Patients were included if they were at least 18 years of age, had sustained uncontrolled HTN, and were of a minority race or ethnicity. The primary outcome was proportion of patients achieving a BP of < 140/90 mm Hg in the intervention group compared with a control group. Secondary outcomes included mean change in BP from baseline, number and type of visits, and number and type of interventions.
Results:
A total of 110 patients were enrolled in this study, 55 patients in each cohort. The baseline characteristics were generally well balanced between the 2 groups. The mean age was 62 years, and most patients were female and African American. For the primary outcome, 70.9% of the patients in the intervention group achieved a BP of < 140/90 mm Hg compared with 32.7% of the patients in the control group (P < 0.001). The most common intervention was lifestyle modifications, followed by BP monitoring technique education and medication adherence interventions.
Conclusion:
In this study, pharmacist-led interventions resulted in clinically and statistically significant improvements in sustained uncontrolled HTN among minority populations.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Drug Therapy
Antianxiety Medications
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

